Hormone receptor status and endocrine therapy in a prospective observation study on trastuzumab (Herceptin (R)) in the adjuvant treatment of breast cancer

P Dall; K Friedrichs; V Petersen; A Hinke; Cosima Brucker; P Schmidt; A von der Assen; P Jungberg; B Bohnsteen

doi:10.1158/0008-5472.SABCS-P5-21-02

Hormone receptor status and endocrine therapy in a prospective observation study on trastuzumab (Herceptin (R)) in the adjuvant treatment of breast cancer

P Dall, K Friedrichs, V Petersen, A Hinke, Cosima Brucker, P Schmidt, A von der Assen, P Jungberg, B Bohnsteen

Department of Gynaecology and Obstetrics

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	CANCER RESEARCH
Volume	72
DOIs	https://doi.org/10.1158/0008-5472.SABCS-P5-21-02
Publication status	Published - 2012

Access to Document

10.1158/0008-5472.SABCS-P5-21-02

Cite this

Dall, P., Friedrichs, K., Petersen, V., Hinke, A., Brucker, C., Schmidt, P., von der Assen, A., Jungberg, P., & Bohnsteen, B. (2012). Hormone receptor status and endocrine therapy in a prospective observation study on trastuzumab (Herceptin (R)) in the adjuvant treatment of breast cancer. CANCER RESEARCH , 72. https://doi.org/10.1158/0008-5472.SABCS-P5-21-02

Dall, P ; Friedrichs, K ; Petersen, V et al. / Hormone receptor status and endocrine therapy in a prospective observation study on trastuzumab (Herceptin (R)) in the adjuvant treatment of breast cancer. In: CANCER RESEARCH 2012 ; Vol. 72.

@article{dfa43090ff1942e5b9c54432eed076f2,

title = "Hormone receptor status and endocrine therapy in a prospective observation study on trastuzumab (Herceptin (R)) in the adjuvant treatment of breast cancer",

author = "P Dall and K Friedrichs and V Petersen and A Hinke and Cosima Brucker and P Schmidt and {von der Assen}, A and P Jungberg and B Bohnsteen",

year = "2012",

doi = "10.1158/0008-5472.SABCS-P5-21-02",

language = "English",

volume = "72",

journal = "CANCER RESEARCH ",

issn = "0008-5472",

publisher = "Amer Assoc Cancer Research",

}

Dall, P, Friedrichs, K, Petersen, V, Hinke, A, Brucker, C, Schmidt, P, von der Assen, A, Jungberg, P & Bohnsteen, B 2012, 'Hormone receptor status and endocrine therapy in a prospective observation study on trastuzumab (Herceptin (R)) in the adjuvant treatment of breast cancer', CANCER RESEARCH , vol. 72. https://doi.org/10.1158/0008-5472.SABCS-P5-21-02

Hormone receptor status and endocrine therapy in a prospective observation study on trastuzumab (Herceptin (R)) in the adjuvant treatment of breast cancer. / Dall, P; Friedrichs, K; Petersen, V et al.
In: CANCER RESEARCH , Vol. 72, 2012.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Hormone receptor status and endocrine therapy in a prospective observation study on trastuzumab (Herceptin (R)) in the adjuvant treatment of breast cancer

AU - Dall, P

AU - Friedrichs, K

AU - Petersen, V

AU - Hinke, A

AU - Brucker, Cosima

AU - Schmidt, P

AU - von der Assen, A

AU - Jungberg, P

AU - Bohnsteen, B

PY - 2012

Y1 - 2012

U2 - 10.1158/0008-5472.SABCS-P5-21-02

DO - 10.1158/0008-5472.SABCS-P5-21-02

M3 - Abstract (Journal)

SN - 0008-5472

VL - 72

JO - CANCER RESEARCH

JF - CANCER RESEARCH

ER -

Dall P, Friedrichs K, Petersen V, Hinke A, Brucker C, Schmidt P et al. Hormone receptor status and endocrine therapy in a prospective observation study on trastuzumab (Herceptin (R)) in the adjuvant treatment of breast cancer. CANCER RESEARCH . 2012;72. doi: 10.1158/0008-5472.SABCS-P5-21-02